Annual Operating Margin
-133.72%
+104.11%+43.77%
31 December 2023
Summary:
Esperion Therapeutics annual operating profit margin is currently -133.72%, with the most recent change of +104.11% (+43.77%) on 31 December 2023. During the last 3 years, it has fallen by -80.37% (-150.65%). ESPR annual operating margin is now -150.65% below its all-time high of -53.35%, reached on 31 December 2020.ESPR Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Margin
-31.04%
-34.53%-989.40%
30 September 2024
Summary:
Esperion Therapeutics quarterly operating profit margin is currently -31.04%, with the most recent change of -34.53% (-989.40%) on 30 September 2024. Over the past year, it has increased by +50.01% (+61.70%). ESPR quarterly operating margin is now -151.00% below its all-time high of 60.86%, reached on 30 June 2020.ESPR Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ESPR Operating Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +43.8% | +61.7% |
| 3 y3 years | -150.7% | +92.0% |
| 5 y5 years | - | +99.5% |
ESPR Operating Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -150.7% | +53.7% | -159.2% | +92.0% |
| 5 y | 5 years | -150.7% | +53.7% | -151.0% | +99.5% |
| alltime | all time | -150.7% | +100.0% | -151.0% | +99.5% |
Esperion Therapeutics Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -31.04%(-989.4%) |
| June 2024 | - | 3.49%(-93.3%) |
| Mar 2024 | - | 52.47%(-139.9%) |
| Dec 2023 | -133.72%(-43.8%) | -131.37%(+62.1%) |
| Sept 2023 | - | -81.05%(-43.6%) |
| June 2023 | - | -143.71%(-28.1%) |
| Mar 2023 | - | -199.78%(-11.6%) |
| Dec 2022 | -237.83%(-17.7%) | -225.92%(+3.0%) |
| Sept 2022 | - | -219.30%(-21.1%) |
| June 2022 | - | -277.99%(+21.8%) |
| Mar 2022 | - | -228.23%(-36.8%) |
| Dec 2021 | -289.02% | -361.20%(-6.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -386.88%(+383.5%) |
| June 2021 | - | -80.01%(-92.3%) |
| Mar 2021 | - | -1038.15%(+4.7%) |
| Dec 2020 | -53.35%(-15.0%) | -991.59%(-52.8%) |
| Sept 2020 | - | -2101.51%(-3553.0%) |
| June 2020 | - | 60.86%(-101.5%) |
| Mar 2020 | - | -4045.98%(-32.6%) |
| Dec 2019 | -62.75%(-100.0%) | -6004.48%(-10.4%) |
| Sept 2019 | - | -6704.18%(+19.1%) |
| June 2019 | - | -5631.16%(-9519.8%) |
| Mar 2019 | - | 59.78% |
| Dec 2000 | -1.38 M%(+11.5%) | - |
| Dec 1999 | -1.24 M% | - |
FAQ
- What is Esperion Therapeutics annual operating profit margin?
- What is the all time high annual operating margin for Esperion Therapeutics?
- What is Esperion Therapeutics annual operating margin year-on-year change?
- What is Esperion Therapeutics quarterly operating profit margin?
- What is the all time high quarterly operating margin for Esperion Therapeutics?
- What is Esperion Therapeutics quarterly operating margin year-on-year change?
What is Esperion Therapeutics annual operating profit margin?
The current annual operating margin of ESPR is -133.72%
What is the all time high annual operating margin for Esperion Therapeutics?
Esperion Therapeutics all-time high annual operating profit margin is -53.35%
What is Esperion Therapeutics annual operating margin year-on-year change?
Over the past year, ESPR annual operating profit margin has changed by +104.11% (+43.77%)
What is Esperion Therapeutics quarterly operating profit margin?
The current quarterly operating margin of ESPR is -31.04%
What is the all time high quarterly operating margin for Esperion Therapeutics?
Esperion Therapeutics all-time high quarterly operating profit margin is 60.86%
What is Esperion Therapeutics quarterly operating margin year-on-year change?
Over the past year, ESPR quarterly operating profit margin has changed by +50.01% (+61.70%)